JAC Advance Access published online on January 24, 2008
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkn003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Thermostable nuclease: a study of clinical impact
Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge CB2 2QW, UK
* Corresponding author. Tel: +01223-257035; Fax: +01223-242775; E-mail: davidaenoch@hotmail.com
Key Words: bacteraemia , Staphylococcus aureus , rapid diagnosis
| The first 10% of the full text of this article appears below. |
Sir,
Bacteraemia due to Staphylococcus aureus is associated with a high morbidity and mortality. Early detection and treatment is critical for successful management. Unfortunately, coagulase-negative staphylococci (CoNS) are the most frequent isolates grown from blood cultures, many of which are considered skin contaminants. A test that rapidly and accurately discriminates the two would potentially allow earlier treatment of S. aureus, while reducing unnecessary antimicrobial use. Thermostable nuclease (TSN) is
Funding
Transparency declarations